MDT DEF 14A DEF-14A Report Dec. 11, 2015 | Alphaminr
Medtronic plc

MDT DEF 14A Report ended Dec. 11, 2015

MEDTRONIC PLC
10-Ks and 10-Qs
10-Q
Quarter ended Oct. 25, 2024
10-Q
Quarter ended July 26, 2024
10-K
Fiscal year ended April 26, 2024
10-Q
Quarter ended Jan. 26, 2024
10-Q
Quarter ended Oct. 27, 2023
10-Q
Quarter ended July 28, 2023
10-K
Fiscal year ended April 28, 2023
10-Q
Quarter ended Jan. 27, 2023
10-Q
Quarter ended Oct. 28, 2022
10-Q
Quarter ended July 29, 2022
10-K
Fiscal year ended April 29, 2022
10-Q
Quarter ended Jan. 28, 2022
10-Q
Quarter ended Oct. 29, 2021
10-Q
Quarter ended July 30, 2021
10-K
Fiscal year ended April 30, 2021
10-Q
Quarter ended Jan. 29, 2021
10-Q
Quarter ended Oct. 30, 2020
10-Q
Quarter ended July 31, 2020
10-K
Fiscal year ended April 24, 2020
10-Q
Quarter ended Jan. 24, 2020
10-Q
Quarter ended Oct. 25, 2019
10-Q
Quarter ended July 26, 2019
10-K
Fiscal year ended April 26, 2019
10-Q
Quarter ended Jan. 25, 2019
10-Q
Quarter ended Oct. 26, 2018
10-Q
Quarter ended July 27, 2018
10-K
Fiscal year ended April 27, 2018
10-Q
Quarter ended Jan. 26, 2018
10-Q
Quarter ended Oct. 27, 2017
10-Q
Quarter ended July 28, 2017
10-K
Fiscal year ended April 28, 2017
10-Q
Quarter ended Jan. 27, 2017
10-Q
Quarter ended Oct. 28, 2016
10-Q
Quarter ended July 29, 2016
10-K
Fiscal year ended April 29, 2016
10-Q
Quarter ended Jan. 29, 2016
10-Q
Quarter ended Oct. 30, 2015
10-Q
Quarter ended July 31, 2015
10-K
Fiscal year ended April 24, 2015
10-Q
Quarter ended Jan. 23, 2015
PROXIES
DEF 14A
Filed on Aug. 9, 2024
DEF 14A
Filed on Aug. 11, 2023
DEF 14A
Filed on Aug. 19, 2022
DEF 14A
Filed on Aug. 27, 2021
DEF 14A
Filed on Aug. 14, 2020
DEF 14A
Filed on Aug. 16, 2019
DEF 14A
Filed on Aug. 24, 2018
DEF 14A
Filed on Aug. 28, 2017
DEF 14A
Filed on Aug. 10, 2016
DEF 14A
Filed on July 24, 2015
TABLE OF CONTENTS
Proxy SummaryProxy StatementProxy SolicitationVoting at the MeetingCautionary Note Regarding Forward-Looking StatementsProposal 1 Election of DirectorsDirectors and NomineesDirector IndependenceRelated Transactions and Other MattersGovernance of MedtronicOur Corporate Governance PrinciplesLead Director and Chairman; Executive SessionsBoard Role in Risk OversightCommittees of the Board and MeetingsDirector CompensationComplaint Procedure; Communications with DirectorsOur Codes of ConductShare Ownership InformationCompensation Discussion and Analysis (CD&A)Executive SummaryDetailed InformationExecutive Compensation PhilosophyElements of Executive CompensationExecutive Compensation Peer ReviewFiscal Year 2015 Compensation DecisionsFiscal Year 2015 Annual and Long-Term Incentive Plan PayoutsCompensation Committee ReportExecutive Compensation2015 Summary Compensation Table2015 Grants of Plan-Based Awards2015 Outstanding Equity Awards at Fiscal Year End2015 Option Exercises and Stock Vested2015 Pension Benefits2015 Nonqualified Deferred CompensationPotential Payments Upon Termination or Change of ControlEquity Compensation Plan InformationReport of the Audit CommitteeAudit and Non-Audit FeesProposal 2 Ratification of Selection of Independent Registered Public Accounting FirmProposal 3 Advisory Resolution to Approve Named Executive Officer Compensation (Say-on-Pay)Proposal 4 Advisory Vote on Resolution to Approve Frequency of Say-on-Pay VotesOther InformationExpenses of SolicitationShareholder Proposals and Director NominationsDelivery of Documents to Shareholders Sharing an AddressOtherAppendix A A-1